Notificaciones De Seguridad De Campo acerca de BioMatrix NeoFlex drug eluting coronary stent system

Swedish data is current through 2018. All of the data comes from the Swedish Medical Products Agency, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Sweden.

FSCA/2013/0001, Vk_20130814_23